Global Iclusig Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI898523
- March 20, 2019
- Global
- 98 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Iclusig market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Iclusig market."
Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome“positive (Ph+) acute lymphoblastic leukemia(ALL).
The global Iclusig market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Iclusig volume and value at global level, regional level and company level. From a global perspective, this report represents overall Iclusig market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
ARIAD Pharmaceuticals
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
45mg
15mg
Segment by Application
CML
ALL
Table of Contents
Executive Summary
1 Iclusig Market Overview
1.1 Product Overview and Scope of Iclusig
1.2 Iclusig Segment by Type
1.2.1 Global Iclusig Production Growth Rate Comparison by Type (2014-2025)
1.2.2 45mg
1.2.3 15mg
1.3 Iclusig Segment by Application
1.3.1 Iclusig Consumption Comparison by Application (2014-2025)
1.3.2 CML
1.3.3 ALL
1.4 Global Iclusig Market by Region
1.4.1 Global Iclusig Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Iclusig Market Size
1.5.1 Global Iclusig Revenue (2014-2025)
1.5.2 Global Iclusig Production (2014-2025)
2 Global Iclusig Market Competition by Manufacturers
2.1 Global Iclusig Production Market Share by Manufacturers (2014-2019)
2.2 Global Iclusig Revenue Share by Manufacturers (2014-2019)
2.3 Global Iclusig Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Iclusig Production Sites, Area Served, Product Types
2.5 Iclusig Market Competitive Situation and Trends
2.5.1 Iclusig Market Concentration Rate
2.5.2 Iclusig Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Iclusig Production Market Share by Regions
3.1 Global Iclusig Production Market Share by Regions
3.2 Global Iclusig Revenue Market Share by Regions (2014-2019)
3.3 Global Iclusig Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Iclusig Production
3.4.1 North America Iclusig Production Growth Rate (2014-2019)
3.4.2 North America Iclusig Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Iclusig Production
3.5.1 Europe Iclusig Production Growth Rate (2014-2019)
3.5.2 Europe Iclusig Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Iclusig Production (2014-2019)
3.6.1 China ...
| read more...
Related Reports
